Design of a Phase 2/3 Adaptive Trial Evaluating Inaxaplin in APOL1-Mediated Kidney Disease

Ronald Falk,Laura Barisoni,David Friedman,Debbie Gipson,Michael Lipkowitz,Akinlolu Ojo,Martin Pollak, Madalina Chirieac, Mariana Faria-Urbina,Yang Song, George Manos, Anna Ferreira, Ogo I. Egbuna,Glenn Chertow

Journal of the American Society of Nephrology(2022)

Cited 0|Views6
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined